Last update:2023.11.24
SOT Webinars
PCRM-NURA webinars
Emulate webinars
Scitovation webinars
Cancer AI Research: Computational Approaches Addressing Imperfect Data (NCI)
NC3Rs Webinar
Title | Update |
NC3Rs「10 years of CRACK IT」
-The worm that turned the tide on in vivo DART testing
-Virtual laboratories for non-animal disease research and toxicity testing
-Chipping away at in vivo nephrotoxicity testing
-Putting in vitro platforms at the heart of cardiotoxicity testing
-3D retinal organoids - a vision of the future
-Using microfluidics to eliminate surgical embryo transfer in mice
-Assessing the genotoxic potential of gene therapy products in vitro
|
2021.12.20 |
Webinar on Inhalation Toxicity Testing (PSCI, US EPA)
OECD webinars
CAAT Webinars
Lush Prize Conference
Title | Update |
ICCVAM Public Forum 2022
-Welcome and Introductions
-Consumer Product Safety Commission Guidance on New Approach Methodologies
-USDA Animal Welfare Information Center
-EPA Activities on NAMs: Update from the Office of Pesticide Programs
-EPA Office of Research and Development: Update on Alternatives Research Activities
-Regulatory Science Tools for Accelerating Innovation in Toxicology Reviews
-FDA Update on Advancing Alternatives for Regulatory Use
-OECD Test Guidelines Programme Update
-3Rs Assessment of Animal Toxicity Data
-Carcinogenicity Testing for the 21st Century
-Activities of the Developmental Neurotoxicity Health Effects Innovation Program
-Microphysiological Systems Applications for Predictive Toxicology
-Investigating DNA Adduct Formation by Flavor Chemicals and Tobacco Byproduct in E-cigarettes Using In Silico Approaches
-EPA Activities on New Approach Methods: Update from the Office of Pollution Prevention and Toxics
-NICEATM Update
-ICCVAM Workgroup Updates
-Measurement Science in ICCVAM
-Cardiovascular Health Effects Innovation Program Update
|
2022.8.8 |
ICCVAM Public Forum 2021
-Welcome and Introductions
-NICEATM and NTP Update
-ICCVAM Workgroup Updates
-Consumer Product Safety Commission Guidance for Industry and Test Method Developers
-USDA Animal Welfare Information Center
-Application of NAMs, Surrogates, and Read-across in Rapid Development of PBPK Models for Human Health Risk Assessment
-Investigation of Parathion-induced Neurotoxicity in SHSY5Y Cells Demonstrates Utility of the Assay as an Alternative Animal Model
-Assessment of Acute Oral Toxicity for Mixtures Using In Silico Modeling Methods
-Alternative Approaches to Ecotoxicological Testing and Assessment
-Impact of Alternatives to Animals in VA Research
-Update on EPA ORD New Approach Method Research Activities
-Recent Progress Towards Reducing Animal Use & Adopting NAMs at EPA's Office of Pesticide Programs
-OPPT's Progress Implementing the Near-term Activities in the TSCA Strategic Plan
-Advancing Alternative Methods at FDA
-Measurement Science Activities Under ICCVAM
-OECD Test Guidelines Programme Update
|
2021.7.20 |
ICCVAM Public Forum 2020
-Welcome and Introductions
-Reflections on 20 Years of ICCVAM
-ICCVAM Workgroup Updates
-NICEATM Update
-Update on FDA Activities on Alternative Methods
-IATA for Developmental Neurotoxicity
-Update on Alternatives Research Activities at EPA
-EPA Office of Pesticide Programs
-Update from EPA/OSCPP/OPPT
-USDA Animal Welfare Information Center
-59MDW Science and Technology Overview and Upcoming Toxicology Projects
-OSHA Update to ICCVAM
-NCATS Update on Tox21 Activities
-Measurement Science Activities Under ICCVAM
-OECD Test Guidelines Programme Update
|
2020.5.21 |
Title | Update |
CAAT 40th Anniversary Symposium
-Developmental NeuroToxicity (DNT)
-Evidence-based Toxicology Collaboration (EBTC)
-Good Cell Culture Practice (GCCP) Program
-Green Toxicology
-Cosmetic and TestSmart Program
-Education program
-Refinement Program
-World Congress on Alternatives
-Policy Program
-Future Perspectives
|
2022.1.19 |
3Rs across Europe webinar series
3Rs Symposium (AWIC, OLAW, JHMI-MCP, CAAT)
Title | Update |
10⁄19 Webinars
-Overview of EPA NAMs Work Plan
-Progress on Implementing the TSCA Alternatives Strategic Plan
-Using Chemical, Biological, and In Vivo Data for NAMs: Which data do we have, and what can we do with it?
-Transcriptome-Based Derivation of an In Vivo POD: Current and Future Utility
-Drugmonizome and Drugmonizome-ML: Integration and Abstraction of Small Molecule Attributes for Drug Set Enrichment Analysis and Machine Learning
-"Fit for Purpose" for Organotypic Models in Environmental Health Protection
|
2020.12.2 |
10⁄20 Webinars
-Retrofitting an Estrogen Receptor Transactivation Assay with Metabolic Competence
-In Vitro Disposition of Tox21 Chemicals: Initial Results and Next Steps
-An OECD Harmonized Template (OHT) to Report NAM Results in Regulatory Environments: Principles and Practical Use
-Case Study #1: Integration of NAM Data for Evaluating Potential Developmental Neurotoxicity
-Case Study #2: Integration of NAM Data in a Next Generation Risk Assessment for Cosmetic Ingredients
-Case Study #3: Incorporating the Threshold of Toxicological Concern into Regulatory Decisions under the Amended Toxic Substances Control Act
|
2020.12.2 |
Title | Update |
8⁄25 Webinars
-Coronavirus Research - Anything Goes?
-Animal Models and Alternatives for COVID-19 Research
-Research Response of the European Commission to Address the COVID-19 Pandemic
|
2020.9.4 |
8⁄26 Webinars
-COVID-19 – What is in the Box of Alternative Methods??
-Human Pluripotent Stem Cell Models for COVID-19 Disease Modeling and Drug Screening
-3Rs and COVID-19 Vaccine Development: Regulatory Aspects
|
2020.9.4 |
The collection of webinar videos is efforted for the promotion of alternative methods. The copyright of webinar videos belongs to whose original providers.